Adamas to present at upcoming svb leerink cns forum

Emeryville, calif.--(business wire)--adamas pharmaceuticals, inc. (nasdaq: adms), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that the company will present “what's happening in parkinson's disease & the gocovri opportunity” at the svb leerink cns forum on tuesday, june 29th at 1:10 pm eastern time. the presentation will be broadcast live from the investor relations section of the ad
ADMS Ratings Summary
ADMS Quant Ranking